Emerging evidence denoted that inhibition of intestinal FXR-FGF15 signaling resulted in prevention against high fat diet (HFD)-induced obesity and liver steatosis (Jiang et al., 2015a; Degirolamo et al., 2015). This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.